Why it matters
The problem it solves.
When you practise regenerative medicine on your own, it's easy to feel that colleagues think you 'do weird stuff'. That isolation makes good clinicians hesitant. A shared mechanism to discuss cases encourages people to be braver — and keeps standards high across the whole community.
Two kinds of discussion
Before you treat — or after.
Before you treat
Prospective discussion
Sense-check indication, patient selection and plan with the panel before you proceed.
After you treat
Retrospective discussion
Review outcomes and complications openly, so the whole group learns from real practice.
How to bring a case
Async or live — your choice.
What you get back
A written opinion — approved by our board.
Every case ends with a considered professional opinion. Before it reaches you, it is reviewed and signed off by our Scientific Advisory Board — so what you receive carries the weight of the organisation, not just one clinician.
01
Discuss the case
Prospective or retrospective, async or live — you present, the panel discusses.
02
We draft our opinion
The panel writes a considered, professional I AM Regen opinion on the case.
03
SAB sign-off
Our Scientific Advisory Board reviews and approves it for accuracy and standards.
04
Sent to you
You receive the approved, organisation-backed written opinion to act on.
Who can bring a case
Included for members — open to everyone.
2 / year
Members
Two case discussions included in your annual membership.
2 / year
Fellows
Two included — and fellows host and chair the panel.
€500
Non-members
Welcome to bring a case, charged per case discussed.